Navigation Links
NIH-funded researchers begin trial of Shigella vaccine candidates
Date:2/20/2013

Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children. The Phase I clinical trial, funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will evaluate the vaccines for safety and their ability to induce immune responses among 90 healthy adults ages 18 to 45 years. The trial is being conducted at the Cincinnati Children's Hospital Medical Center, one of the eight NIAID-funded Vaccine and Treatment Evaluation Units in the United States.

Shigella infection, called shigellosis, is an intestinal disease spread via contact with infected feces, by consumption of contaminated food or water or by contact with a contaminated surface. Symptoms include diarrhea, abdominal pain, fever, nausea and vomiting. In healthy adults, the infection generally clears on its own in five to seven days, but if left untreated, can lead to hospitalization or death, especially among young children and adults with weakened immune systems.

According to the World Health Organization, shigellosis causes roughly 90 million cases of severe disease each year and 108,000 deaths, most of which occur in the developing world and affect children under 5 years of age. In the United States, 14,000 shigellosis cases are reported annually, with most cases occurring among children ages 1 to 4 years.

Antibiotics are the standard treatment for patients with shigellosis, but drug-resistant strains of the bacterium are becoming more common.

"It seems that Shigella bacteria know our immune system better than we do," said William Alexander, Ph.D., a program officer in NIAID's Enteric and Hepatic Diseases Branch, Div
'/>"/>

Contact: Nalini Padmanabhan
padmanabhannm@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NIH-funded study finds high HIV infection rates among gay and bisexual black men in the US
2. NIH-funded analysis estimates effective PrEP dosing
3. NIH-funded trial launched to assess experimental TB drug
4. Better stroke care, everywhere: NIH-funded study boosts local hospitals clotbuster use
5. NIH awards $20 million over 5 years to train next generation of global health researchers
6. Researchers develop a new cell and animal model of inflammatory breast cancer
7. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
8. Researchers Find Gene Mutations That May Be a Key to Autism
9. Researchers find evidence of banned antibiotics in poultry products
10. NJ stroke researchers report advances in spatial neglect research at AAN Conference
11. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... ... assistPoint Partners, LLC is proud to announce a ... Through a secure web portal, assistPoint connects Life Sciences, Patients and Providers together ... and workflow solution. This provides cancer center patient advocates, financial counselors and business ...
(Date:8/4/2015)... FL (PRWEB) , ... August 04, 2015 , ... ... testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced their ... has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a time. ...
(Date:8/4/2015)... ... ... Bayco Products, Inc. announces a new industrial-grade LED Dual-LightTM headlamp in a ... have a flip-up face shield. The sleek contours of the new Nightstick NSP-4614B ... their headlamp when raising or lowering their face shield or visor. The 4614 will ...
(Date:8/4/2015)... ... 2015 , ... Worldwide Power Products acquires new assets, certifying ... in Texas. Effective July 1st of this year, Worldwide Power Products acquired operations ... the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 generators in ...
(Date:8/4/2015)... VEGAS, Nevada (PRWEB) , ... August 04, 2015 , ... ... of radio interviews to discuss his new book, The Pain Antidote , which ... Medical Director of Las Vegas Recovery Center’s Chronic Pain Treatment Program, wrote the book ...
Breaking Medicine News(10 mins):Health News:assistPoint.com Web Site Launched 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:North Texas Acquisition Press Release 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3
... have discovered more details about how an energy sensing ... their energy reserves. In a report in the ... showed that a chemical modification on the thermostat protein ... stored energy, and with it, they default to stockpiling ...
... Denise Mann HealthDay Reporter , TUESDAY, Feb. 21 ... to take a second look at the weight loss pill ... about heart problems and possible birth defects. While effective ... denied approval in 2010 because of its potential side effects. ...
... BEER-SHEVA, February 21, 2012 A simple blood test is ... (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that ... Prof. Kapelushnik of BGU,s Faculty of Health Sciences and his ... than a teaspoon of blood. The test uses infrared light ...
... A Cedars-Sinai research scientist has been awarded two national ... Research Project Grant from the National Institutes of Health ... Terrence Town, PhD, is studying drugs that potentially ... plaques that build up in the brain and are ...
... News) -- Watching a lot of movies that feature alcohol ... these teens are more likely to progress to binge drinking, ... findings suggest that U.S. movie makers should adopt the same ... The study included more than 6,500 U.S. kids, aged 10 ...
... British Columbia - Blocking autophagy -- the process of "self-eating" ... way to enhance the effectiveness of a wide variety of ... acidic inner cell part, which acts like a stomach and ... says Ravi K. Amaravadi, MD, an assistant professor of Medicine ...
Cached Medicine News:Health News:Cell energy sensor mechanism discovered 2Health News:FDA Weighs Fate of Qnexa for Weight Loss, Again 2Health News:FDA Weighs Fate of Qnexa for Weight Loss, Again 3Health News:Cedars-Sinai awarded $2.5 million to study potential new drug treatments for Alzheimer's disease 2Health News:Booze in Movies May Fuel Teenage Drinking 2Health News:New combo of chemo and well-known malaria drug delivers double punch to tumors 2
(Date:8/4/2015)... , Aug. 4, 2015  Delcath Systems, Inc. (NASDAQ: ... company focused on oncology with an emphasis on the ... two abstracts summarizing data from studies in ... the Delcath Hepatic CHEMOSAT ® Delivery System (CHEMOSAT) will ... Oncology (EADO) annual congress, which will be held in ...
(Date:8/4/2015)... DIEGO , Aug. 4, 2015 ... three-dimensional biology company focused on delivering scientific and ... that the Company has hired Paul Gallant ... vitro tissue service and product business. Mr. Gallant has ... experience in the drug discovery industry, most recently ...
(Date:8/4/2015)... , Aug. 4, 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: ... and epigenetic drivers of cancer, will be presenting at the ... at 1:55 p.m. ET (10:55 a.m. PT) in ... Ph.D., president and CEO of Mirati, will provide a corporate ... will be accessible on the "Investors" page of Mirati,s corporate ...
Breaking Medicine Technology:Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 2Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 3Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress 4Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 2Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 3
... Designs, a company specializing in fashionable medical ID bracelets ... available in an additional 1,100 pharmacies by the end of ... products to more than 1,800. The company ... offering stylish key chains, necklaces, flash drives and bracelets available ...
... 2011 A new prostate cancer study ... surgical treatment to "watchful waiting" revealed important findings ... currently debating their treatment options. (Photo:   ... offered clinical options for early prostate cancer treatment ...
Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 3
... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
... explanation of foldable intraocular lenses. The instrument ... placed under the implant and divides the ... helps support both halves of the lens ... in the anterior chamber is avoided. The ...
Medicine Products: